Q3 2019 Holdings
Filed 2019-11-14 | 80 holdings | $32.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $7.1M | 73,773 | 21.8% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $5.6M | 1,069,089 | 17.3% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $4.4M | 205,281 | 13.6% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $4.4M | 38,581 | 13.5% |
| Burlington Stores Inc(BURL) | COM | 122017106 | $3.9M | 19,500 | 12.0% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $3.2M | 90,000 | 10.0% |
| Charter Communications Inc N(CHTR) | CL A | 16119P108 | $2.5M | 6,000 | 7.6% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $763.0K | 500,000 | 2.3% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $56.3K | 1,109,900 | 0.2% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $51.8K | 400,000 | 0.2% |
| Gilead Sciences Inc(GILD) | CALL | 375558103 | $44.7K | 705,000 | 0.1% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $39.6K | 470,000 | 0.1% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $32.4K | 700,000 | 0.1% |
| Celgene Corp(CELG) | COM | 151020104 | $24.8K | 250,000 | 0.1% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $23.5K | 2,930,320 | 0.1% |
| Novo-Nordisk A S(NVO) | ADR | 670100205 | $23.3K | 450,000 | 0.1% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $18.7K | 248,038 | 0.1% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $16.2K | 165,713 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $14.9K | 2,082,643 | 0.0% |
| Teva Pharmaceutical Inds LTD(TEVA) | CALL | 881624209 | $10.7K | 1,550,000 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $10.5K | 310,000 | 0.0% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $8.5K | 74,000 | 0.0% |
| Mellanox Technologies LTD | SHS | M51363113 | $8.4K | 76,875 | 0.0% |
| Nice LTD(NSY) | SPONSORED ADR | 653656108 | $8.2K | 57,193 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $8.1K | 565,000 | 0.0% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $8.0K | 335,817 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $7.7K | 660,000 | 0.0% |
| Caesarstone LTD(CSTE) | ORD SHS | M20598104 | $7.7K | 461,509 | 0.0% |
| Microsoft Corp(MSFT) | COM | 594918104 | $7.5K | 53,741 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $7.4K | 346,380 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $7.0K | 177,500 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $7.0K | 260,000 | 0.0% |
| Fiserv Inc(FISV) | COM | 337738108 | $7.0K | 67,279 | 0.0% |
| Palo Alto Networks Inc(PANW) | COM | 697435105 | $6.7K | 32,976 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $6.7K | 310,000 | 0.0% |
| Exicure Inc(XCUR) | COM | 30205M101 | $6.7K | 2,637,988 | 0.0% |
| Forescout Technologies Inc(FSCTEUR) | COM | 34553D101 | $6.6K | 173,696 | 0.0% |
| Audiocodes LTD(AUDC) | ORD | M15342104 | $6.2K | 328,263 | 0.0% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $5.9K | 762,018 | 0.0% |
| Neos Therapeutics Inc(NEOS) | COM | 64052L106 | $5.8K | 3,908,265 | 0.0% |
| Verint SYS Inc(VTY) | COM | 92343X100 | $5.8K | 134,489 | 0.0% |
| Solaredge Technologies Inc(SEDG) | COM | 83417M104 | $5.4K | 64,002 | 0.0% |
| Allot LTD(ALLT) | SHS | M0854Q105 | $5.3K | 661,031 | 0.0% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $5.3K | 915,000 | 0.0% |
| Harpoon Therapeutics Inc | COM | 41358P106 | $5.1K | 374,031 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $5.1K | 63,269 | 0.0% |
| Y Mabs Therapeutics Inc(YMABUSD) | COM | 984241109 | $5.0K | 190,000 | 0.0% |
| Chiasma Inc(CHMA) | COM | 16706W102 | $4.9K | 990,000 | 0.0% |
| Axovant Gene Therapies LTD | COM | G0750W203 | $4.3K | 668,541 | 0.0% |
| WIX COM LTD(WIX) | SHS | M98068105 | $4.3K | 36,890 | 0.0% |